Your browser doesn't support javascript.
loading
Virology and immune dynamics reveal high household transmission of ancestral SARS-CoV-2 strain.
Tosif, Shidan; Haycroft, Ebene R; Sarkar, Sohinee; Toh, Zheng Quan; Do, Lien Anh Ha; Donato, Celeste M; Selva, Kevin J; Hoq, Monsurul; Overmars, Isabella; Nguyen, Jill; Lee, Lai-Yang; Clifford, Vanessa; Daley, Andrew; Mordant, Francesa L; McVernon, Jodie; Mulholland, Kim; Marcato, Adrian J; Smith, Miranda Z; Curtis, Nigel; McNab, Sarah; Saffery, Richard; Kedzierska, Katherine; Subarrao, Kanta; Burgner, David; Steer, Andrew; Bines, Julie E; Sutton, Philip; Licciardi, Paul V; Chung, Amy W; Neeland, Melanie R; Crawford, Nigel W.
Afiliación
  • Tosif S; Department of Paediatrics, The University of Melbourne, Parkville, Victoria, Australia.
  • Haycroft ER; Infection and Immunity, Murdoch Children's Research Institute, Parkville, Victoria, Australia.
  • Sarkar S; Department of General Medicine, The Royal Children's Hospital Melbourne, Parkville, Victoria, Australia.
  • Toh ZQ; Department of Microbiology and Immunology, Peter Doherty Institute for Infection and Immunity, The University of Melbourne, Parkville, Victoria, Australia.
  • Do LAH; Department of Paediatrics, The University of Melbourne, Parkville, Victoria, Australia.
  • Donato CM; Infection and Immunity, Murdoch Children's Research Institute, Parkville, Victoria, Australia.
  • Selva KJ; Department of Paediatrics, The University of Melbourne, Parkville, Victoria, Australia.
  • Hoq M; Infection and Immunity, Murdoch Children's Research Institute, Parkville, Victoria, Australia.
  • Overmars I; Department of Paediatrics, The University of Melbourne, Parkville, Victoria, Australia.
  • Nguyen J; Infection and Immunity, Murdoch Children's Research Institute, Parkville, Victoria, Australia.
  • Lee LY; Department of Paediatrics, The University of Melbourne, Parkville, Victoria, Australia.
  • Clifford V; Infection and Immunity, Murdoch Children's Research Institute, Parkville, Victoria, Australia.
  • Daley A; Department of Microbiology and Immunology, Peter Doherty Institute for Infection and Immunity, The University of Melbourne, Parkville, Victoria, Australia.
  • Mordant FL; Clinical Epidemiology and Biostatistics Unit, Murdoch Children's Research Institute, Parkville, Victoria, Australia.
  • McVernon J; Infection and Immunity, Murdoch Children's Research Institute, Parkville, Victoria, Australia.
  • Mulholland K; Infection and Immunity, Murdoch Children's Research Institute, Parkville, Victoria, Australia.
  • Marcato AJ; Department of Microbiology, The Royal Children's Hospital Melbourne, Parkville, Victoria, Australia.
  • Smith MZ; Department of Paediatrics, The University of Melbourne, Parkville, Victoria, Australia.
  • Curtis N; Infection and Immunity, Murdoch Children's Research Institute, Parkville, Victoria, Australia.
  • McNab S; Department of Microbiology, The Royal Children's Hospital Melbourne, Parkville, Victoria, Australia.
  • Saffery R; Infectious Diseases Unit, The Royal Children's Hospital Melbourne, Melbourne, Victoria, Australia.
  • Kedzierska K; Department of Microbiology, The Royal Children's Hospital Melbourne, Parkville, Victoria, Australia.
  • Subarrao K; Department of Microbiology and Immunology, Peter Doherty Institute for Infection and Immunity, The University of Melbourne, Parkville, Victoria, Australia.
  • Burgner D; Department of Infectious Diseases, Peter Doherty Institute for Infection and Immunity, University of Melbourne, Parkville, Victoria, Australia.
  • Steer A; Department of Paediatrics, The University of Melbourne, Parkville, Victoria, Australia.
  • Bines JE; Infection and Immunity, Murdoch Children's Research Institute, Parkville, Victoria, Australia.
  • Sutton P; Department of Infectious Diseases, Peter Doherty Institute for Infection and Immunity, University of Melbourne, Parkville, Victoria, Australia.
  • Licciardi PV; Department of Infectious Diseases, Peter Doherty Institute for Infection and Immunity, University of Melbourne, Parkville, Victoria, Australia.
  • Chung AW; Department of Paediatrics, The University of Melbourne, Parkville, Victoria, Australia.
  • Neeland MR; Infection and Immunity, Murdoch Children's Research Institute, Parkville, Victoria, Australia.
  • Crawford NW; Infectious Diseases Unit, The Royal Children's Hospital Melbourne, Melbourne, Victoria, Australia.
Article en En | MEDLINE | ID: mdl-35871459
ABSTRACT

BACKGROUND:

Household studies are crucial for understanding the transmission of SARS-CoV-2 infection, which may be underestimated from PCR testing of respiratory samples alone. We aim to combine the assessment of household mitigation measures; nasopharyngeal, saliva, and stool PCR testing; along with mucosal and systemic SARS-CoV-2-specific antibodies, to comprehensively characterize SARS-CoV-2 infection and transmission in households.

METHODS:

Between March and September 2020, we obtained samples from 92 participants in 26 households in Melbourne, Australia, in a 4-week period following the onset of infection with ancestral SARS-CoV-2 variants.

RESULTS:

The secondary attack rate was 36% (24/66) when using nasopharyngeal swab (NPS) PCR positivity alone. However, when respiratory and nonrespiratory samples were combined with antibody responses in blood and saliva, the secondary attack rate was 76% (50/66). SARS-CoV-2 viral load of the index case and household isolation measures were key factors that determine secondary transmission. In 27% (7/26) of households, all family members tested positive by NPS for SARS-CoV-2 and were characterized by lower respiratory Ct values than low transmission families (Median 22.62 vs. 32.91; IQR 17.06-28.67 vs. 30.37-34.24). High transmission families were associated with enhanced plasma antibody responses to multiple SARS-CoV-2 antigens and the presence of neutralizing antibodies. Three distinguishing saliva SARS-CoV-2 antibody features were identified according to age (IgA1 to Spike 1, IgA1 to nucleocapsid protein (NP)), suggesting that adults and children generate distinct mucosal antibody responses during the acute phase of infection.

CONCLUSION:

Utilizing respiratory and nonrespiratory PCR testing, along with the measurement of SARS-CoV-2-specific local and systemic antibodies, provides a more accurate assessment of infection within households and highlights some of the immunological differences in response between children and adults.
Asunto(s)
Palabras clave

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: SARS-CoV-2 / COVID-19 Tipo de estudio: Diagnostic_studies / Prognostic_studies Límite: Adult / Child / Humans Idioma: En Revista: Pediatr Allergy Immunol Asunto de la revista: ALERGIA E IMUNOLOGIA / PEDIATRIA Año: 2022 Tipo del documento: Article País de afiliación: Australia

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: SARS-CoV-2 / COVID-19 Tipo de estudio: Diagnostic_studies / Prognostic_studies Límite: Adult / Child / Humans Idioma: En Revista: Pediatr Allergy Immunol Asunto de la revista: ALERGIA E IMUNOLOGIA / PEDIATRIA Año: 2022 Tipo del documento: Article País de afiliación: Australia